McGill University and Moderna to expand collaborations with new projects in Lipid Nanoparticle research

Published: 19 July 2023

McGill University today announced it has signed agreements with ModernaTX, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to support two innovative...

McGill University joins Moderna in battle against global health threats

Published: 24 March 2022

McGill University has joined Moderna’s mRNA Access program, which aims to accelerate innovation and enable new vaccines and medicines for emerging and neglected infectious diseases through...

Back to top